Uterotonic · Hormone
Oxytocin (Pitocin)
Also called Pitocin
Indications
- Induction of labor for a medical reason; not for elective induction (label)
- Augmentation of dysfunctional labor (label)
- Prevention of postpartum hemorrhage after delivery, IM or IV (ACOG)
- Treatment of postpartum hemorrhage from atony, the first-line uterotonic (ACOG PB 183)
- Uterine tone at cesarean delivery, as a small slow bolus and an infusion (2019 consensus)
- Adjunct for incomplete or inevitable abortion (label)
Dosing
Oxytocin drip card and mL/h converterStart: Induction, low dose (ACOG): 0.5–2 milliunits/min (label 0.5–1). Postpartum hemorrhage: 10–40 units in 500–1,000 mL, run to keep the uterus firm, or 10 units IM (ACOG). Cesarean (2019 consensus): 1 unit (3 in labor) IV over at least 30 seconds, then 2.5–7.5 units/h (7.5–15 in labor)
On the quick cards
Mechanism of action
Oxytocin binds the oxytocin receptor, a Gq/11-coupled receptor on myometrial cells. Phospholipase C makes IP₃, which releases calcium from the sarcoplasmic reticulum while more enters through membrane channels; calcium–calmodulin activates myosin light-chain kinase, giving stronger and more frequent contractions, and decidual prostaglandin release adds to them. Receptor numbers rise sharply toward term, so the term uterus is very sensitive, and hours of exposure desensitize and internalize the receptors.
Pharmacology
- Uterine: dose-related rise in contraction frequency and force, greatest at term
- Breast: contracts myoepithelial cells, ejecting milk
- Cardiovascular: a fast IV bolus causes vasodilation, hypotension and reflex tachycardia, with ST changes or myocardial ischemia in some
- Renal: likeness to vasopressin gives an antidiuretic effect at high doses, so long infusions in electrolyte-free fluid cause water intoxication and hyponatremia (label)
- Fetal: tachysystole cuts placental perfusion between contractions, causing late decelerations and fetal hypoxemia
Pharmacokinetics
| Onset | IV almost immediate; IM 3–5 min (label) |
|---|---|
| Duration | IV effect fades within 1 h of stopping; IM lasts 2–3 h (label) |
| Steady state | About 40 min after each rate change (Seitchik 1984), the basis of 30–40 min titration steps |
| Half-life | 1–6 min, shorter in late pregnancy (label); some labor studies measured 12–17 min |
| Distribution | Extracellular fluid (label); small amounts probably reach the fetus |
| Metabolism | Oxytocinase (placental aminopeptidase) in pregnancy, plus the liver and kidneys |
| Elimination | Kidneys and liver; little unchanged drug in urine (label) |
| Routes | IV infusion or IM; never a fast undiluted IV push |
Chemistry
- A cyclic nonapeptide, Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH₂, with a disulfide bridge between cysteines 1 and 6; C₄₃H₆₆N₁₂O₁₂S₂, MW 1007 (label)
- Differs from vasopressin only at positions 3 and 8, which explains its weak antidiuretic and pressor cross-reactivity
- Synthetic, so free of the vasopressin in old pituitary extracts (label)
- 10 units/mL with 0.5% chlorobutanol, pH about 3.5 (Pitocin label); heat degrades many products, hence WHO cold-chain advice, though Pitocin is labeled for room temperature
Adverse effects and cautions
In the one-pagers
Practice Obstetric Emergencies questions free76 exam-style questions with rationales on the topic where Oxytocin comes up most. No account or download needed.
In the algorithms
Practice free in your browser2,450+ exam-style questions with rationales. No account, no ads. Also free on the App Store and Google Play.
Sources
- FDA label: Pitocin (Par, 2026)
- ACOG Practice Bulletins 107 (2009) and 183 (2017)
- Heesen 2019 (uterotonics at cesarean)
- Seitchik 1984 (oxytocin kinetics)
For education and exam preparation only. Follow your institution’s protocols. Typical adult values for study. Follow your local protocols and medical direction.